UNSPSC 51171616: Casanthranol

This classification denotes a laxative with the molecular formula C21H22O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3SJ3U7J6V2, chemically known as (10R)-1,8-dihydroxy-3-(hydroxymethyl)-10-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-10H-anthracen-9-one but generally known as casanthranol, which bears US NIH Compound Identifier 51371307. European Medicines Agency schedules Casanthranol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13254MIG.

As of Q4 2014, CASANTHRANOL remains the US FDA Preferred Term for this commodity. Casanthranol bears US NLM identifiers UMLS ID C0205705 and NCI Concept Code C28907. SMILES: C1=CC2=C(C(=C1)O)C(=O)C3=C(C=C(C=C3C2OC4C(C(C(C(O4)CO)O)O)O)CO)O.

UNSPSC 51171616 Casanthranol is a Commodity code that in practice encompasses offender drug testing services, including specimen collection, laboratory screening and confirmation analysis, and result reporting to county criminal justice agencies. State and local procurement under this code reflects the operational and compliance needs of county community supervision and corrections departments managing substance-abuse monitoring for supervised offenders. The work involves staffing collection sites during business and weekend hours, operating randomized testing notification systems, performing multi-panel immunoassay screens with confirmatory testing via LC/MS/MS or GC/MS, and offering alternative matrices such as oral fluid and hair testing. Vendors must maintain SAMHSA, state DPS, or CAP laboratory certification and meet strict pricing and service-level obligations including no surcharges, price-match requirements, and annual price redetermination limits tied to medical Consumer Price Index increases.

Collin County Community Supervision and Corrections Department in Texas is the issuing body represented in recent activity. The department issued RFP 2026-327 for offender specimen collection and drug testing services on September 25, 2026, with an original response deadline of July 23, 2026 (note: the posted date postdates the listed due date, indicating the due date reflects an earlier or corrected deadline). The scope encompasses two collection sites in Plano and McKinney, approximately 25,031 tests annually across five-panel and six-panel screens with confirmatory and ancillary testing, and the estimated contract value is $600,000 over an initial two-year term with three optional one-year renewals. Award was anticipated August 10, 2026. Funding derives from Texas Department of Criminal Justice Community Justice Assistance Division appropriations, subject to annual availability.